IBDEI0S9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13250,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,13251,0)
 ;;=N31.9^^53^589^70
 ;;^UTILITY(U,$J,358.3,13251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13251,1,3,0)
 ;;=3^Neurogenic Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,13251,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,13251,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,13252,0)
 ;;=N31.1^^53^589^71
 ;;^UTILITY(U,$J,358.3,13252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13252,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,13252,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,13252,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,13253,0)
 ;;=N32.89^^53^589^5
 ;;^UTILITY(U,$J,358.3,13253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13253,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,13253,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,13253,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,13254,0)
 ;;=N33.^^53^589^4
 ;;^UTILITY(U,$J,358.3,13254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13254,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,13254,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,13254,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,13255,0)
 ;;=N34.2^^53^589^99
 ;;^UTILITY(U,$J,358.3,13255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13255,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,13255,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,13255,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,13256,0)
 ;;=N34.1^^53^589^100
 ;;^UTILITY(U,$J,358.3,13256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13256,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,13256,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,13256,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,13257,0)
 ;;=N39.0^^53^589^104
 ;;^UTILITY(U,$J,358.3,13257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13257,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,13257,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,13257,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,13258,0)
 ;;=N31.0^^53^589^72
 ;;^UTILITY(U,$J,358.3,13258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13258,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,13258,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,13258,2)
 ;;=^5015644
 ;;^UTILITY(U,$J,358.3,13259,0)
 ;;=R31.9^^53^589^54
 ;;^UTILITY(U,$J,358.3,13259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13259,1,3,0)
 ;;=3^Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,13259,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,13259,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,13260,0)
 ;;=R31.0^^53^589^52
 ;;^UTILITY(U,$J,358.3,13260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13260,1,3,0)
 ;;=3^Hematuria,Gross
 ;;^UTILITY(U,$J,358.3,13260,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,13260,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,13261,0)
 ;;=R31.2^^53^589^53
 ;;^UTILITY(U,$J,358.3,13261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13261,1,3,0)
 ;;=3^Hematuria,Microscopic
 ;;^UTILITY(U,$J,358.3,13261,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,13261,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,13262,0)
 ;;=R31.1^^53^589^51
 ;;^UTILITY(U,$J,358.3,13262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13262,1,3,0)
 ;;=3^Hematuria,Benign Essential Microscopic
 ;;^UTILITY(U,$J,358.3,13262,1,4,0)
 ;;=4^R31.1
 ;;^UTILITY(U,$J,358.3,13262,2)
 ;;=^5019326
 ;;^UTILITY(U,$J,358.3,13263,0)
 ;;=N40.0^^53^589^30
 ;;^UTILITY(U,$J,358.3,13263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13263,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,13263,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,13263,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,13264,0)
 ;;=N40.1^^53^589^29
